James D. Crapo resigned as a director and chief executive officer of Omni Bio Pharmaceutical, Inc. effective August 31, 2012. The company's board of directors appointed Steven M. Bathgate, a director, to serve as interim chief executive officer of the company beginning August 31, 2012 until a successor is appointed.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+21.20% | 127B | |
+24.99% | 117B | |
+25.59% | 27.77B | |
-19.86% | 20.44B | |
-14.36% | 16.62B | |
-13.18% | 15.92B | |
-46.67% | 14.94B | |
+12.50% | 14.74B | |
+56.73% | 14.38B |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Announces Executive Changes